Literature DB >> 11452105

Cancer. What does radiotherapy do to endothelial cells?

J Folkman1, K Camphausen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11452105     DOI： 10.1126/science.1062892

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  22 in total

1.  Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation.

Authors:  Giovanni Battista Levi Sandri; Giuseppe Maria Ettorre; Marco Colasanti; Edoardo De Werra; Gianluca Mascianà; Daniele Ferraro; Giovanni Tortorelli; Rosa Sciuto; Pierleone Lucatelli; Giuseppe Pizzi; Ubaldo Visco-Comandini; Giovanni Vennarecci
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

2.  MicroRNA expression after ionizing radiation in human endothelial cells.

Authors:  Mechthild Wagner-Ecker; Christian Schwager; Ute Wirkner; Amir Abdollahi; Peter E Huber
Journal:  Radiat Oncol       Date:  2010-03-26       Impact factor: 3.481

3.  Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway.

Authors:  Sunil K Manna; Govindarajan T Ramesh
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

4.  Recombinant human endostatin combined with definitive chemoradiotherapy as primary treatment for patients with unresectable but without systemic metastatic squamous cell carcinoma of the oesophagus.

Authors:  Z Zhong; X Gu; Z Zhang; D Wang; Y Qing; M Li; N Dai
Journal:  Br J Radiol       Date:  2012-08-16       Impact factor: 3.039

5.  Radiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours.

Authors:  A Abramyuk; V Hietschold; S Appold; R von Kummer; N Abolmaali
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

6.  Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent.

Authors:  Dan Jia; Nathan A Koonce; Roopa Halakatti; Xin Li; Shmuel Yaccoby; Frances L Swain; Larry J Suva; Leah Hennings; Marc S Berridge; Scott M Apana; Kevin Mayo; Peter M Corry; Robert J Griffin
Journal:  Radiat Res       Date:  2010-06       Impact factor: 2.841

Review 7.  Organoids as Complex In Vitro Models for Studying Radiation-Induced Cell Recruitment.

Authors:  Benjamin C Hacker; Marjan Rafat
Journal:  Cell Mol Bioeng       Date:  2020-06-15       Impact factor: 2.321

Review 8.  Clinical biomarkers of angiogenesis inhibition.

Authors:  Aaron P Brown; Deborah E Citrin; Kevin A Camphausen
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

9.  Improved effect of an antiangiogenic tyrosine kinase inhibitor (SU5416) by combinations with fractionated radiotherapy or low molecular weight heparin.

Authors:  Eva L Lund; Minna W B Olsen; Kenneth E Lipson; Gerald McMahon; Anthony R Howlett; Paul E G Kristjansen
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

Review 10.  Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.

Authors:  Riad Salem; Vincenzo Mazzaferro; Bruno Sangro
Journal:  Hepatology       Date:  2013-10-04       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.